Approach to the patients with the hallucinations, in the Parkinson’s disease in the low-income country and environment of restricted medications and stigmas
Objective: Expose the percentage of patients with hallucinations in studying group of Parkinson’s disease patients in Uzbekistan. Background: Uzbekistan has 35 million population, largest in…Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus
Objective: To examine whether patients with Parkinson's disease (PD) and isolated minor hallucinations have increased plasma neurofilament light chain (NfL) levels and/or differences in white…Homer1 polymorphism in patients with Parkinson’s disease and psychosis
Objective: To explore the association of psychosis in Parkinson’s disease with polymorphisms of HOMER1, a gene whose product (Homer1) is responsible for modulating the metabotropic…Increased illusory responses in non-hallucinating, cognitively impaired Lewy body disease patients
Objective: To determine whether non-hallucinating Lewy body disease-spectrum patients report increased illusory responses. Background: Pareidolias are specific illusions of faces and objects perceived in formless…Impaired colour discrimination is associated with hallucinations in Dementia with Lewy Bodies
Objective: To explore the hypothesis that color discrimination impairment seen in Lewy body disorders is a specific biomarker of visual hallucinations rather than just overall…Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration
Objective: To test whether increased reliance on prior knowledge is associated with visual hallucinations in Lewy Body Disease (LBD: Parkinson’s disease and Dementia with Lewy…Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease
Objective: To assess the daily variability of visual and autonomic nervous system (ANS) functions in relation to sleep disorders to determine circadian PD phenotypes Background:…Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study
Objective: To describe the prevalence and characteristics of Olfactory Hallucinations (OlfH) in patients with Parkinson’s Disease (PD) in a tertiary movement clinic. Background: Hallucinations are…Relationship between RBD and olfactory disorder, clinical symptoms in Parkinson’s disease
Objective: We aimed to assess the association among RBD, olfactory function and clinical symptoms in patients with Parkinson's disease (PD). Background: Rapid eye movement sleep…Visual subnetwork dysfunction in Parkinson’s patients with primary visual hallucinations
Objective: To evaluate impairments in the visual subnetwork in Parkinson’s disease (PD) patients with psychosis using BOLD fMRI Background: Psychosis occurs in 20-70% of patients…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 11
- Next Page »